ecancermedicalscience

Conference Report

Eurocan Platform meeting: European recommendations for biomarker-based chemoprevention trials

8 Dec 2014
Linda Cairns

Chemoprevention or the now more preferred ‘cancer prevention’ is the long-term administration of a biological or chemical agent to reduce the risk of cancer. This approach has long been active in individuals at high risk of developing breast or colon cancer. The aim of this expert meeting was to review the current status of the field of cancer prevention and potential, emerging biomarkers specifically focusing on breast, colon, and lung cancer but also with sessions on ovary and prostate.

Related Articles

Adnan-Mustafiz Chowdhury, Sattam A Halaseh, Debora Joseph, Abel I Abel, Nikita Jha, Amro Al-Karadsheh, Hakam Al-Karadsheh, Omar A Salem, Sama F Salaitah, Noor M Arman, Georges Rizkallah
Intissar Belrhali, Ibrahim El Ghissassi, Boutaina Cherkaoui, Oumaima Lamsyah, Khaoula Ouchen, Soufiane Bel Rhali, Saoussane Kharmoum, Sarah Naciri, Hanane Inrhaoun, Siham Lkhoyaali, Salma Najm, Hind Mrabti, Hassan Errihani
Kevin Guzmán, Vanessa Pabón, Andrés Angulo, Luis E Bravo, Arsenio Hidalgo, Carol Rosero, Alvaro Pazos
Rachael O Oduyemi, Chizoma Millicent Ndikom, Gloria Oluwakorede Alao, Iyanuoluwa O Ojo, Faith Ayomide Ajayi, Damilola Ajibade, Abdullahi Suleiman, Hameedah Ayomide Gbadamosi, Oluwadamilare Akingbade
Agnes Chipo Tererai, Margaret Borok, Zvavahera Mike Chirenje, Liz Gwyther, Lindsay Farrant, Ntokozo Ndlovu, Simbarashe Rusakaniko